Last reviewed · How we verify

NCT05886855

Evaluation of PerioMonitor for Detection of Oral Inflammatory Load (OIL) in Human Subjects.

Status unknown Last updated 2 June 2023
What this trial tests

trial in Oral Inflammation in 400 participants. Status unknown.

Timeline
24 May 2023
Primary endpoint
20 December 2023
31 January 2024

Quick facts

Lead sponsorOral Science International Inc.
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date24 May 2023
Primary completion20 December 2023
Estimated completion31 January 2024

Conditions studied

Sponsor

Oral Science International Inc.

Who can join

18 and older, any sex, with Oral Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this multicenter, prospective, single arm Study is to evaluate the efficacy and safety of PerioMonitor as an aid to the detection of oral inflammation associated with periodontal diseases. PerioMonitor is an IVD device for the rapid, semi-quantitative detection of neutrophil enzyme activity in oral samples. This test is intended for prescription use at Point-of-Care ("POC") settings by health care professionals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prognostic utility of oral neutrophil counts in high-risk periodontitis: A retrospective study.
    Prete BRJ, Barbour A, Sun C, Tenenbaum HC, et al · · 2025 · cited 1× · PMID 40627761 · DOI 10.1002/jper.11360

Verify or expand the search:

Other Oral Science International Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05886855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing